PRESS RELEASE published on 01/13/2025 at 18:00, 1 year 1 month ago Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Atlas Special Opportunities, LLC converted 4 convertible bonds in Oxurion, leading to a EUR 100,000 capital increase. Oxurion focuses on developing vision-preserving therapeutics for the elderly Capital Increase Oxurion Atlas Special Opportunities, LLC Innovative Therapeutics Elderly Vision
BRIEF published on 01/06/2025 at 18:05, 1 year 1 month ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Transparency Biopharmaceutical Shareholding Atlas Special Opportunities Oxurion
PRESS RELEASE published on 01/06/2025 at 18:00, 1 year 1 month ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Oxurion NV received a transparency notification from Atlas Special Opportunities, LLC revealing a stake above 15% threshold due to purchase of voting securities Transparency Notification Biopharmaceutical Atlas Special Opportunities Ophthalmic Therapies Oxurion NV
BRIEF published on 01/03/2025 at 18:05, 1 year 2 months ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Shares Transparency Biopharmaceutical Atlas Special Opportunities Oxurion
PRESS RELEASE published on 01/03/2025 at 18:00, 1 year 2 months ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Oxurion NV received a transparency notification under Belgian Transparency legislation from Atlas Special Opportunities, LLC, regarding the sale of voting securities Transparency Notification Atlas Special Opportunities LLC Oxurion NV Belgian Legislation Retinal Disease Therapy
BRIEF published on 12/31/2024 at 18:05, 1 year 2 months ago Oxurion Postpones Strategic Transaction Due to Ongoing Discussions Report Strategic Transaction Oxurion Leuven Financial Discussions
PRESS RELEASE published on 12/31/2024 at 18:00, 1 year 2 months ago Oxurion Announces Postponement of Signing for Strategic Transaction Due to Ongoing Discussions Oxurion NV announces a short postponement of approximately four weeks for the signing of its strategic transaction due to better than expected financial results of the target. Parties are committed to finalizing the agreement as a key priority Financial Results Commitment Postponement Strategic Transaction Oxurion NV
Published on 03/05/2026 at 20:00, 2 hours 33 minutes ago PPX Hosts Medical Outreach Campaign for Local Communities
Published on 03/05/2026 at 17:55, 4 hours 38 minutes ago ACCESS Newswire to Host Fourth Quarter and Year End Earnings Conference Call on March 19, 2026
Published on 03/05/2026 at 14:00, 8 hours 33 minutes ago EQ Inc. Secures Strategic Partnership with Global Card Network to Expand Integrated Rewards Across Canada
Published on 03/05/2026 at 14:00, 8 hours 33 minutes ago GameSquare's Stream Hatchet Publishes 2025 YouTube Gaming Trends Report
Published on 03/05/2026 at 14:00, 8 hours 33 minutes ago Horizon Aircraft's Unique VTOL Delivers Up to 75% Lower Operating Costs Than Helicopters
Published on 03/05/2026 at 19:49, 2 hours 43 minutes ago EQS-Adhoc: Northern Data Announces Preliminary Q4 2025 revenue and FY 2026 outlook
Published on 03/05/2026 at 19:15, 3 hours 17 minutes ago Huawei Wins Eight GLOMO Awards at MWC Barcelona 2026
Published on 03/05/2026 at 19:05, 3 hours 27 minutes ago Supercharging Edge AI: Apacer Launches Industrial Grade Storage for Raspberry Pi Platforms
Published on 03/05/2026 at 18:40, 3 hours 53 minutes ago 2025 Full-year results FREY: a pan-European platform already creating value
Published on 03/05/2026 at 18:34, 3 hours 58 minutes ago Mersen: Number of shares and voting rights as of February 28, 2026